Sanginita Chemicals to Hold EGM on April 11 for Capital Increase & Preferential Issue
Sanginita Chemicals will hold an EGM on April 11, 2026, to increase authorized share capital by ₹50 crore and raise borrowing limits to ₹100 crore. The company will also issue equity shares worth ₹25 crore for cash and in lieu of acquiring Agastya Green Energy Limited's stake.
The proposed actions, including a substantial increase in authorized capital, preferential issuance of shares for acquisition, and increased borrowing limits, are material events that can significantly impact the company's financial structure, growth prospects, and market position.
The announcement details significant corporate actions including capital increase, preferential issuance of shares for acquisition and cash, and increased borrowing powers, which are generally seen as positive steps for growth and strategic expansion.
Sanginita Chemicals Limited has announced an Extra Ordinary General Meeting (EGM) scheduled for April 11, 2026, at 04:00 PM IST, to be conducted via Video Conferencing (VC) or Other Audio Visual Means (OAVM). The primary agenda items include increasing the company's authorized share capital by ₹50 crore, from ₹27 crore to ₹77 crore, by creating an additional 5,00,00,000 equity shares of ₹10 each. This will amend the capital clause in the Memorandum of Association.
The EGM will also seek approval to increase the threshold for loans, guarantees, and investments in securities under Section 186 of the Companies Act, 2013, up to ₹100 crore. Furthermore, the company plans to issue equity shares on a preferential basis for consideration other than cash and for cash.
For consideration other than cash, up to 1,52,87,356 equity shares of ₹10 each will be issued at an issue price of ₹13.05 per share (including a premium of ₹3.05) to BNG Investment LLC, in lieu of their entire 100% stake in Agastya Green Energy Limited (AGEL). The relevant date for determining the issue price is March 12, 2026.
Additionally, up to 1,91,57,080 equity shares of ₹10 each will be issued at ₹13.05 per share (including a premium of ₹3.05), aggregating to ₹24,99,99,894, to BNG Investment LLC for cash consideration via private placement. The relevant date for this issuance is also March 12, 2026.
Lastly, the company seeks to increase the borrowing powers of the Board under Section 180(1)(c) of the Companies Act, 2013, to borrow up to ₹100 crore.
What to do with a filing like this
Sanginita Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under egm. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sanginita Chemicals Limited. Read the original for the full detail.